Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 25 (EEF1A1P25)

Target
EEF1A1P25
Molecular classification
Other (Pseudogene)
01

Overview

EEF1A1P25 is a human processed pseudogene, one of many derived from EEF1A1, the gene encoding eukaryotic translation elongation factor 1 alpha 1. Pseudogenes like EEF1A1P25 generally do not code for functional proteins and have no established molecular or therapeutic function. While some pseudogenes of elongation factors may be transcribed or regulate the parental gene through RNA-based mechanisms, there is no current evidence that EEF1A1P25 is functional or involved in disease, drug interaction, or clinical biomarker applications. EEF1A1 is critical for protein synthesis by mediating the delivery of aminoacyl-tRNAs to the ribosome. Its pseudogenes, including EEF1A1P25, are typically non-coding "processed pseudogenes," resulting from retrotransposition events. The function (if any) of most EEF1A1-derived pseudogenes remains unclear, and they are not recognized as drug targets or molecular biomarkers. No records indicate EEF1A1P25 as having alternate names, being misspelled, or incorrectly annotated; rather, it is a legitimate genomic pseudogene entry. EEF1A1P25 does not encode a receptor, enzyme, or targetable protein and has no documented clinical relevance beyond its status as a processed pseudogene. Its only established alias is its canonical abbreviation.

Other names
EEF1A1P25
02

Mechanism of action

None known

03

Biological functions

None established for pseudogene; parental gene (EEF1A1) is involved in translational elongation
04

Disease associations

None established for this pseudogene; EEF1A1 and related elongation factors are broadly implicated in cancer and other diseases, but pseudogene-specific contributions are unconfirmed
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None established for pseudogene

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 25 (EEF1A1P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 25 (EEF1A1P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call